4th Quarter - Report
WILLIAMS AND JENSEN, PLLC for BAYER CORPORATION
Client
Income
$20,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues affecting R&D tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | Sch. C, Treasury; LD, Rep. Scott McInnis |
| TESS ILLOS | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Drug rebates for Medicare Part D; Independent Payment Advisory Board (IPAB).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| GEORGE OLSEN | — |
| ANTHONY J RODA | — |
Health Issues HCR
Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Prescription drug advertising; Federal preemption for prescription drugs; Implementation of Patient Protection and Affordable Care Act; drug shortages; Work on 21st Century Cures Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.